Summary
Statins one of the most sucessful class of drugs in the history of Pharma business is about to be retired or loose is exclusivity in controlled markets.
What do you do with your best performers once the Job is accomplished in one department.
Transfer him to another to get the job done.
This is the underlying principle adopted the pharma companies to move around their best performers to extract what ever can be from them
Analysis
Statins have reached their peak performance in Cardio segment, and have delivered in terms of profits expected from them.
What do you do now to your best performers, move them around to other departments to extract what ever is left in them.
This seems to the underlying principle adopted here and in many ways similar to ever greening of molecules done to extend patent life.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
